GlassScriptPhysician profile
Aamir A Abbas
NPI 1487948030
$4,699.50
in general payments reported to CMS, 2019-2025
23 companies · $2,097 in 2025
The $2,097 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $340 · 2020: $169 · 2021: $337 · 2022: $280 · 2023: $1,156 · 2024: $320 · 2025: $2,097.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,697 · Food and Beverage: $1,076 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,697.24 |
| Food and Beverage | $1,075.94 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,982.89 | 2020-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Vertex Pharmaceuticals Incorporated | $800.00 | 2023 | |
| Cvrx, INC. | $794.69 | 2024-2025 | Barostim Neo System |
| Bolton Medical INC | $274.05 | 2021 | |
| Medtronic Vascular, INC. | $132.76 | 2019 | |
| Pfizer INC. | $119.61 | 2019-2020 | |
| Abiomed | $101.84 | 2019 | |
| Myocardial Solutions, INC. | $63.21 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $46.04 | 2022-2024 | Farxiga |
| Philips North America LLC | $45.90 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.12 | 2022 | |
| Amgen INC. | $39.69 | 2022-2025 | Repatha |
| Merck Sharp & Dohme LLC | $34.30 | 2022-2023 | |
| Irhythm Technologies, INC. | $33.29 | 2024 | Zio Monitor, Zio Xt Patch |
| Baxter Healthcare | $27.56 | 2024 | Hillrom - Carnation Ambulatory Monitor |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Analog Devices INC. | $24.95 | 2025 | Sensinel Cpm Wearable |
| Novartis Pharmaceuticals Corporation | $22.95 | 2024 | |
| Astellas Pharma US INC | $22.32 | 2022 | |
| Janssen Pharmaceuticals, INC | $20.54 | 2022 | |
| Boston Scientific Corporation | $19.25 | 2024 | Bodyguardian |
| United Therapeutics Corporation | $18.29 | 2024 | Tyvaso |
| Novo Nordisk INC | $17.68 | 2024 | Rybelsus, Ozempic |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.57 | 2019-2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aamir Abbas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.